An 11-strong team from Salford-based company Hettich UK took on the challenge of climbing England and Wales’ highest peaks within a day to raise funds for Pancreatic Cancer Research Fund.
A group of keen sailors set out to compete in the UK’s largest sailing race in tribute to their friend and fellow crew member who died of pancreatic cancer.
The recent news that the drug olaparib delayed the progress of advanced pancreatic cancer in patients who have faults in the BRCA1 and 2 genes underlines the relevance and importance of a PCRF-funded research project being carried out by Dr Mairéad McNamara from the University of Manchester and The Christie NHS Foundation Trust.
A ‘precision drug’ designed to target specific genetic faults within cancer cells has caused cautious excitement, by delaying the progression of some advanced pancreatic cancers after chemotherapy treatment.
Seven innovative research projects tackling pancreatic cancer have been awarded grants by the national charity Pancreatic Cancer Research Fund (PCRF) totalling £1.2M.
We’re not exactly sure what the collective noun for a group of superheroes is (a marvel?), but wow, what an incredible performance the Gayton family put on at the 2019 Brighton Heroes fun run in May.
Katie Whybrow and her family welcomed hundreds of people through the gates of Lower Wilbury Farm in Letchworth on Sunday 24 March, for the annual ‘Lambing Live’ event which they run each year for charity.
The brilliant Leeds RAG Fashion Show on 28 February raised over £23,000 on the night for its two charities, PCRF and Behind Closed Doors – more than double the previous year’s total!
The Leeds RAG Fashion Show – the annual flagship event in the calendar of Leeds University Union’s charity fundraising society – takes place on 28 February 2019, with PCRF as one of its nominated charities.
The first study in the world to take a detailed look at scar tissue that surrounds pancreatic cancer tumours – also known as the stroma - has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.